Arena Pharmaceuticals

$65.50
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.11 (+0.17%) Today
$0.00 (0.00%) As of 8:00 PM EST after-hours

Why Robinhood?

You can buy or sell ARNA and other stocks, options, and ETFs commission-free!

About ARNA

Arena Pharmaceuticals, Inc. Common Stock, also called Arena Pharmaceuticals, is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protien-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in San Diego, CA. The listed name for ARNA is Arena Pharmaceuticals, Inc. Common Stock.

CEO
Amit Dilip Munshi
Employees
320
Headquarters
San Diego, California
Founded
1997
Market Cap
3.81B
Price-Earnings Ratio
Dividend Yield
Average Volume
1.35M
High Today
$66.98
Low Today
$65.00
Open Price
$65.33
Volume
396.52K
52 Week High
$90.19
52 Week Low
$32.95

Collections

ARNA Earnings

-$2.28
$3.11
$8.50
$13.89
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Feb 24, After Hours

You May Also Like